JP2024523005A - 性機能の調節、心血管系及び脳血管系の保護、肝細胞再生の促進、腫瘍の予防及び／又は処置、並びに免疫及び睡眠の質の改善における、アルコールと冷感剤との組成物の使用 - Google Patents

性機能の調節、心血管系及び脳血管系の保護、肝細胞再生の促進、腫瘍の予防及び／又は処置、並びに免疫及び睡眠の質の改善における、アルコールと冷感剤との組成物の使用 Download PDF

Info

Publication number
JP2024523005A
JP2024523005A JP2023575352A JP2023575352A JP2024523005A JP 2024523005 A JP2024523005 A JP 2024523005A JP 2023575352 A JP2023575352 A JP 2023575352A JP 2023575352 A JP2023575352 A JP 2023575352A JP 2024523005 A JP2024523005 A JP 2024523005A
Authority
JP
Japan
Prior art keywords
composition
acid
alcohol
cooling agent
ppm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023575352A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024523005A5 (enExample
Inventor
▲張▼雪峰
▲馬▼国霞
Original Assignee
青海春天▲薬▼用▲資▼源科技股▲分▼有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 青海春天▲薬▼用▲資▼源科技股▲分▼有限公司 filed Critical 青海春天▲薬▼用▲資▼源科技股▲分▼有限公司
Publication of JP2024523005A publication Critical patent/JP2024523005A/ja
Publication of JP2024523005A5 publication Critical patent/JP2024523005A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Alcoholic Beverages (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2023575352A 2021-06-02 2022-01-27 性機能の調節、心血管系及び脳血管系の保護、肝細胞再生の促進、腫瘍の予防及び／又は処置、並びに免疫及び睡眠の質の改善における、アルコールと冷感剤との組成物の使用 Pending JP2024523005A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202110614624 2021-06-02
CN202110614624.2 2021-06-02
PCT/CN2022/074407 WO2022252663A1 (zh) 2021-06-02 2022-01-27 酒精和凉味剂的组合物在调节性功能、保护心脑血管系统、促进肝细胞再生、抗肿瘤、提高免疫及睡眠质量上的用途

Publications (2)

Publication Number Publication Date
JP2024523005A true JP2024523005A (ja) 2024-06-25
JP2024523005A5 JP2024523005A5 (enExample) 2025-04-30

Family

ID=80754836

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023575352A Pending JP2024523005A (ja) 2021-06-02 2022-01-27 性機能の調節、心血管系及び脳血管系の保護、肝細胞再生の促進、腫瘍の予防及び／又は処置、並びに免疫及び睡眠の質の改善における、アルコールと冷感剤との組成物の使用

Country Status (8)

Country Link
US (1) US20240252453A1 (enExample)
EP (1) EP4353263B1 (enExample)
JP (1) JP2024523005A (enExample)
CN (1) CN114225038A (enExample)
ES (1) ES3072893T3 (enExample)
FI (1) FI4353263T3 (enExample)
PT (1) PT4353263T (enExample)
WO (1) WO2022252663A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114225038A (zh) * 2021-06-02 2022-03-25 青海春天药用资源科技股份有限公司 酒精和凉味剂组合物在调节性功能、护血管、肝细胞再生、抗肿瘤、提高免疫及睡眠的用途
CN115590967A (zh) * 2022-10-20 2023-01-13 青海春天药用资源科技股份有限公司（Cn） 酒精、凉味剂和有机酸的组合物在制备降血压及改善绝经期女性激素水平的组合物上的用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002527385A (ja) * 1998-10-13 2002-08-27 ファイザー・プロダクツ・インク セルトラリン経口濃縮物
JP2006036694A (ja) * 2004-07-27 2006-02-09 Nakamurado:Kk 米糠等発酵調合液の製造方法
JP2016136867A (ja) * 2015-01-26 2016-08-04 サントリーホールディングス株式会社 果実酒
CN109022223A (zh) * 2017-06-09 2018-12-18 宜宾凉露酒业有限公司 凉口型配制酒及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1240826A (zh) * 1999-04-01 2000-01-12 康宏杰 清凉型酒
JP2010239872A (ja) * 2009-04-01 2010-10-28 Sanei Gen Ffi Inc 食用酸を含有する製品中のメントールの苦味低減方法
CN108079202A (zh) * 2017-01-25 2018-05-29 青海春天药用资源科技利用有限公司 具有改善睡眠，增强机体免疫力功效的药物组合物及制法
CN109022188B (zh) * 2017-06-09 2022-02-22 宜宾听花酒业发展有限责任公司 采用强化曲制备凉口型白酒的方法
RU2650712C1 (ru) * 2018-01-19 2018-04-17 Писарницкий Александр Фомич Композиция ингредиентов для мятного коктейля
CN109248226A (zh) * 2018-11-22 2019-01-22 福泉星合养生发展有限公司 一种理疗保健油
CN112425708A (zh) * 2020-12-08 2021-03-02 南通亚香食品科技有限公司 一种饮品凉味剂组分及其制备工艺
CN114225038A (zh) * 2021-06-02 2022-03-25 青海春天药用资源科技股份有限公司 酒精和凉味剂组合物在调节性功能、护血管、肝细胞再生、抗肿瘤、提高免疫及睡眠的用途
CN115590967A (zh) * 2022-10-20 2023-01-13 青海春天药用资源科技股份有限公司（Cn） 酒精、凉味剂和有机酸的组合物在制备降血压及改善绝经期女性激素水平的组合物上的用途

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002527385A (ja) * 1998-10-13 2002-08-27 ファイザー・プロダクツ・インク セルトラリン経口濃縮物
JP2006036694A (ja) * 2004-07-27 2006-02-09 Nakamurado:Kk 米糠等発酵調合液の製造方法
JP2016136867A (ja) * 2015-01-26 2016-08-04 サントリーホールディングス株式会社 果実酒
CN109022223A (zh) * 2017-06-09 2018-12-18 宜宾凉露酒业有限公司 凉口型配制酒及其制备方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KAZADI LUBOBO‐CLAUDE ET AL., EXPERIMENTAL PHYSIOLOGY, vol. 103, no. 10, JPN6025001669, 2018, pages 1302 - 1308, ISSN: 0005508118 *
中国食品, vol. 第11期, JPN6025001668, 2021, pages 88 - 93, ISSN: 0005508117 *
佐藤 充克: "赤ワイン・ポリフェノールの健康効果", NEW FOOD INDUSTRY, vol. 41, no. 11, JPN6025001667, pages 55 - 64, ISSN: 0005626022 *
島津 善美 他, J. BREW. SOC. JAPAN., vol. 77, no. 9, JPN6025001670, 1982, pages 623 - 627, ISSN: 0005626023 *

Also Published As

Publication number Publication date
EP4353263A1 (en) 2024-04-17
FI4353263T3 (fi) 2026-07-03
US20240252453A1 (en) 2024-08-01
CN114225038A (zh) 2022-03-25
ES3072893T3 (en) 2026-07-06
EP4353263A4 (en) 2024-11-06
WO2022252663A1 (zh) 2022-12-08
PT4353263T (pt) 2026-07-16
EP4353263B1 (en) 2026-05-06

Similar Documents

Publication Publication Date Title
TWI583390B (zh) 富含鞣花單寧之萃取物組成物
JP2004521919A (ja) 抗ストレス機能、抗疲労機能、月経前期症候群及び月経痛緩和機能及び脳神経栄養因子としての機能を有する酵母由来機能性ペプチド及びその製造方法
CN102355898A (zh) 能量消耗促进剂
EP4353263B1 (en) Composition of alcohol and cooling agent for regulating sexual functions, protecting cardiovascular and cerebrovascular systems, promoting regeneration of liver cells, and improving immunity and sleep quality
JPWO2016175136A1 (ja) 筋脂肪化抑制用組成物
US9364474B2 (en) Method for treatment of neurologic dysfunction
US20190046469A1 (en) Compositions and methods for treating mood disorders or skin disease or damage
CN102802641B (zh) 用于预防或治疗过敏性疾病的包含含氘的水的组合物及其制备方法
CN115590967A (zh) 酒精、凉味剂和有机酸的组合物在制备降血压及改善绝经期女性激素水平的组合物上的用途
CN108473536B (zh) 用于预防或治疗炎症性疾病的肽及其用途
US9839651B1 (en) Food supplement for restoring male sex drive (libido)
US11464756B1 (en) Mecuna pruriens, L-DOPA and 5-HTP based dietary supplements, pharmaceutical formulations and uses thereof
US8440685B1 (en) Method for treatment of neurologic dysfunction
EP3750532A1 (en) A food supplement for use in restoring male sex drive (libido)
RU2377936C1 (ru) Биоактивный напиток
CN108294138A (zh) 一种既能提神醒脑又能缓解疲劳的饮料
RU2633484C2 (ru) Новое применение мелатонина
RU2794098C1 (ru) Антивирусный препарат для инъекций
WO2025182355A1 (ja) 勃起障害改善剤・男性更年期障害改善剤
JP2014162761A (ja) 血中ａｐｏＣＩ濃度低下剤
US20060122261A1 (en) [method of preparing labdane diterpene composition, preferably isoforskolin and deacetylforskolin from forskolin extract and their use for promoting lean body mass and other applications]
JP2006213628A (ja) 抗ストレス剤
RU2782133C2 (ru) Применение фармацевтической композиции β-циклодекстрина с 9-фенил-2,3,4,5,6,7,8,9-октагидро-1Н-селеноксантеном для повышения/восстановления либидо
KR100450496B1 (ko) 숙취 해소용 음료 조성물
JP2009541308A (ja) ヒトの強精のための手段及び方法

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A529

Effective date: 20240131

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240131

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250121

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20250421

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250624

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20251023